(MPSC), a company that specializes in the development of AI predictive analytics for the neonatal intensive care unit (NICU), has been granted Breakthrough Device designation by the US FDA for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback